DSUVIA
AcelRx Pharmaceuticals, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87312320 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Attorney Name | Thomas M. Hadid |
| Law Office Assigned | N30 |
| Employee Name | BURKE, JUSTINE N |
Timeline
| 2017-01-24 | Application Filed |
| 2017-06-23 | Location: TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED |
| 2019-12-30 | Status: Live/Pending |
| 2019-12-30 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  AcelRx Pharmaceuticals, Inc. |
| Address | 351 Galveston Drive Redwood City DE 94063 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260121 | Circles that are totally or partially shaded. |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-01-27 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-01-28 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2017-01-31 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2017-04-19 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-04-19 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-04-19 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-04-19 | 7 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-06-21 | 8 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-06-21 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-06-22 | 10 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2017-06-23 | 11 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2017-06-23 | 12 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2017-06-23 | 13 GNS3 O:Outgoing Correspondence |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2017-12-27 | 14 RCSC S: |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2018-06-27 | 15 RCSC S: |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2018-12-27 | 16 RCSC S: |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2019-06-27 | 17 RCSC S: |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2019-12-30 | 18 RCSC S: |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2020-06-30 | 19 RCSC S: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-01-04 | 20 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-01-20 | 21 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-02-09 | 22 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-02-09 | 23 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-04-06 | 24 NOAM E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2021-11-08 | 25 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2021-11-08 | 26 MAB6 E:E-Mail |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED | 2023-09-05 | 27 WOAR I:Incoming Correspondence |
| WITHDRAWAL OF ATTORNEY GRANTED | 2023-09-05 | 28 WOAG I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 DSUVIA 87312320 not registered Live/Pending |
AcelRx Pharmaceuticals, Inc. 2017-01-24 |
 DSUVIA 86850846 not registered Live/Pending |
AcelRx Pharmaceuticals, Inc. 2015-12-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 